CBMX -

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research8 months ago

    CBMX: Results Remain Very Strong, Despite Record Revenue Streak Ending

    By Brian Marckx, CFA NASDAQ:CBMX Q3 2017:  Results Remain Very Strong, Despite Record Revenue Streak Ending… CombiMatrix (NASDAQ:CBMX) reported financial results for Q3.  While financial results remained ...

  • Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017
    PR Newswire8 months ago

    Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017

    Momentum in base business complemented by strategic expansion into family health genetics Hosting conference call today at 4:30 pm ET / 1:30 pm PT SAN FRANCISCO , Nov. 6, 2017 /PRNewswire/ --  Invitae ...

  • PR Newswire9 months ago

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of CombiMatrix Corporation - CBMX

    NEW YORK , Oct. 12, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...

  • Invitae Commences Exchange Offer for CombiMatrix Series F Warrants
    PR Newswire10 months ago

    Invitae Commences Exchange Offer for CombiMatrix Series F Warrants

    SAN FRANCISCO, Oct. 6, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced that it has commenced an offer to exchange (the "Exchange Offer") each outstanding Series F warrant (CUSIP No. 20009T147) (the "CombiMatrix Series F Warrants") to acquire one share of common stock of CombiMatrix Corporation ("CombiMatrix") for 0.3056 of a share of common stock, par value $0.0001 per share, of Invitae (the "Invitae Common Stock"). The Exchange Offer will expire at 12:00 midnight, New York City time, on November 13, 2017 (one minute after 11:59 p.m., New York City time, on November 12, 2017), or any other date and time to which Invitae extends the Exchange Offer (such date and time, as it may be extended, the "Expiration Date").

  • CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 31, 2017
    Capital Cube11 months ago

    CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 31, 2017

    Categories: Yahoo FinanceGet free summary analysis CombiMatrix Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of CombiMatrix Corp. – Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics, Inc. and RadNet, Inc. (DGX-US, LH-US, NEO-US and RDNT-US) that have also reported for this period. Highlights ... Read more (Read more...)

  • ACCESSWIRElast year

    Today's Research Reports on Trending Tickers: CombiMatrix Corporation and Puma Biotechnology

    NEW YORK, NY / ACCESSWIRE / August 2, 2017 / A strong earnings season continued to push U.S. markets higher Tuesday. The Dow Jones Industrial Average closed at a new record high for the 5th consecutive ...

  • CombiMatrix shares jump on buyout news
    Investing.comlast year

    CombiMatrix shares jump on buyout news

    Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with InVitae Corp (NYSE:NVTA)

  • Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life
    PR Newswirelast year

    Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life

    SAN FRANCISCO, July 31, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced two acquisitions to establish a leading position in family health genetic information services. Invitae has entered into a definitive agreement to acquire privately held Good Start Genetics, a molecular diagnostics company focused on preimplantation and carrier screening for inherited disorders.